Nebraska Medicine Hematology/Oncology

www.nebraskamed.com

 

UNMC Leukemia Symposium: Focus on Opportunities to Improve Care
G

Novel Treatment Options for AML and Overview of Related Trials - Moving from Standard 7+3 to Combinations and Targeting FLT3, CD33, BCL2 and IDH Inhibitors

By UNMC Leukemia Symposium: Focus on Opportunities to Improve Care FEATURING Gail J. Roboz
By UNMC Leukemia Symposium: Focus on Opportunities to Improve Care FEATURING Gail J. Roboz
383 views
July 19, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba

Featured Video

19:25
Pfizer Hematology

Moving Forward in Stage III/IV Classical Hodgkin Lymphoma

Feat. A. Ip
Leukemia Symposium: Focus on Opportunities to Improve Care
13:48

Underutilization of Chemotherapy Among Older Adults with AML

UNMC Leukemia Symposium: Focus on Opportunities to Improve Care

V. Bhatt

240 views
13:35

Disparity in the Use of Allo HSCT in AML - Benefit of Allo Transplan…

UNMC Leukemia Symposium: Focus on Opportunities to Improve Care

Z. Al-Kadhimi

104 views
19:40

Late-Effects of Childhood Leukemia Treatment & Guidelines for Long-t…

UNMC Leukemia Symposium: Focus on Opportunities to Improve Care

M. Acquazzino

16 views
22:50

Palliative vs. Hospice Care & Benefits of Early Integration of Palli…

UNMC Leukemia Symposium: Focus on Opportunities to Improve Care

M. Teply

61 views
40:14

Novel Treatment Options for AML and Overview of Related Trials - Mov…

UNMC Leukemia Symposium: Focus on Opportunities to Improve Care

G. Roboz

383 views
24:40

Panel Discussion on Living with Cancer: How to Manage Balancing Work…

UNMC Leukemia Symposium: Focus on Opportunities to Improve Care